FDA approves Onswik, a once-weekly basal insulin, for adults with type 2 diabetestranslating…

The FDA has approved a once-weekly basal insulin to control glucose levels for adults with type 2 diabetes, Eli Lilly announced.

Factuality

74/100

Political Bias

Center

Ownership

Healio (SLACK Incorporated)

Country

USA

Region

North America

Language

English

Keywords#FDA#Onswik#basal insulin#once-weekly basal#adults